CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Trial of Belzutifan in Patients With Recurrent or Persistent Clear Cell Carcinoma of the Ovary or Clear Cell Carcinoma of Other Gynecologic Origin

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06677190
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:29:00.224796+00:00
Published At: 2025-11-05T00:00:00+00:00
Record Updated At: 2025-11-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Ovarian Cancer", "Ovarian Carcinoma", "Endometrial Cancer", "Uterine Cancer", "Cervical Cancer", "Vulvar Cancer", "Gynecologic Cancer", "Vaginal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-11-05"
protocolSection.identificationModule.nctId: "NCT06677190"
protocolSection.identificationModule.officialTitle: "A Phase II Trial of Belzutifan in Patients With Recurrent or Persistent Clear Cell Carcinoma of the Ovary or Clear Cell Carcinoma of Other Gynecologic Origin"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.